Literature DB >> 19178126

Estimating the cost of diabetes mellitus-related events from inpatient admissions in Sweden using administrative hospitalization data.

Ulf-G Gerdtham1, Philip Clarke, Alison Hayes, Soffia Gudbjornsdottir.   

Abstract

To estimate short- and long-term costs of inpatient hospitalization in Sweden for major diabetes mellitus-related events. Costs were estimated using administrative hospital data from the Swedish National Board of Health and Welfare, which is linked to the Swedish National Diabetes Register. Data were available for 179 749 patients with diabetes in Sweden from 1998 to 2003 (mean and median duration of 6 years' follow-up). Costing of inpatient admissions was based on Nordic diagnosis-related groups (NordDRG). Multiple regression analysis (linear and generalizing estimating equation models) was used to estimate inpatient care costs controlling for age, sex and co-morbidities. The data on hospitalizations were converted to costs (euro) using 2003 exchange rates. The average annual costs (linear model) associated with inpatient admissions for a 60-year-old male in the year the first event first occurred were as follows: euro6488 (95% CI 5034, 8354) for diabetic coma; euro6850 (95% CI 6514, 7204) for heart failure; euro7853 (95% CI 7559, 8144) for non-fatal stroke; euro8121 (95% CI 7104, 9128) for peripheral circulatory complications; euro8736 (95% CI 8474, 9001) for non-fatal myocardial infarction (MI); euro10 360 (95% CI 10 085, 10 643) for ischaemic heart disease; euro11 411 (95% CI 10 298, 12 654) for renal failure; and euro14 949 (95% CI 13 849, 16 551) for amputation. On average, the costs were higher when co-morbidity was accounted for (e.g. MI with co-morbidity was twice as costly as MI alone). Average hospital inpatient costs associated with common diabetes-related events can be estimated using panel data regression methods. These could assist in modelling of long-term costs of diabetes and in evaluating the cost effectiveness of improving care.

Entities:  

Mesh:

Year:  2009        PMID: 19178126     DOI: 10.2165/00019053-200927010-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  16 in total

Review 1.  Guidelines for computer modeling of diabetes and its complications.

Authors: 
Journal:  Diabetes Care       Date:  2004-09       Impact factor: 19.112

2.  The impact of aging on health care expenditure in Sweden.

Authors:  U G Gerdtham
Journal:  Health Policy       Date:  1993-04       Impact factor: 2.980

Review 3.  Swedish healthcare under pressure.

Authors:  Anders Anell
Journal:  Health Econ       Date:  2005-09       Impact factor: 3.046

4.  Diabetes: the cost of illness in Sweden.

Authors:  F Henriksson; B Jönsson
Journal:  J Intern Med       Date:  1998-12       Impact factor: 8.989

5.  The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trial.

Authors:  B Jönsson; J R Cook; T R Pedersen
Journal:  Diabetologia       Date:  1999-11       Impact factor: 10.122

6.  Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered.

Authors:  A Norlund; J Apelqvist; P O Bitzén; P Nyberg; B Scherstén
Journal:  J Intern Med       Date:  2001-07       Impact factor: 8.989

7.  The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care.

Authors:  Soffia Gudbjörnsdottir; Jan Cederholm; Peter M Nilsson; Björn Eliasson
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

8.  A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).

Authors:  P M Clarke; A M Gray; A Briggs; A J Farmer; P Fenn; R J Stevens; D R Matthews; I M Stratton; R R Holman
Journal:  Diabetologia       Date:  2004-10-27       Impact factor: 10.122

9.  Factors influencing the cost of hospital care for people with diabetes in Australia.

Authors:  Philip Clarke; Chris Kelman; Stephen Colagiuri
Journal:  J Diabetes Complications       Date:  2006 Nov-Dec       Impact factor: 2.852

10.  The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).

Authors:  P Clarke; A Gray; R Legood; A Briggs; R Holman
Journal:  Diabet Med       Date:  2003-06       Impact factor: 4.359

View more
  10 in total

1.  The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in Japan.

Authors:  Haruhisa Fukuda; Shunya Ikeda; Takeru Shiroiwa; Takashi Fukuda
Journal:  Pharmacoeconomics       Date:  2016-10       Impact factor: 4.981

2.  Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitus.

Authors:  Hillary R Bogner; Steven D Miller; Heather F de Vries; Sumedha Chhatre; Ravishankar Jayadevappa
Journal:  J Card Fail       Date:  2010-03-06       Impact factor: 5.712

3.  Simulating lifetime outcomes associated with complications for people with type 1 diabetes.

Authors:  Tom W C Lung; Philip M Clarke; Alison J Hayes; Richard J Stevens; Andrew Farmer
Journal:  Pharmacoeconomics       Date:  2013-06       Impact factor: 4.981

4.  Study protocol: a multi-professional team intervention of physical activity referrals in primary care patients with cardiovascular risk factors--the Dalby lifestyle intervention cohort (DALICO) study.

Authors:  Emelie Stenman; Matti E Leijon; Susanna Calling; Christina Bergmark; Daniel Arvidsson; Ulf-G Gerdtham; Kristina Sundquist; Rickard Ekesbo
Journal:  BMC Health Serv Res       Date:  2012-06-22       Impact factor: 2.655

5.  Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden.

Authors:  Johan Jendle; Åsa Ericsson; Barnaby Hunt; William J Valentine; Richard F Pollock
Journal:  Diabetes Ther       Date:  2017-12-04       Impact factor: 2.945

6.  Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes.

Authors:  Arndís Finna Ólafsdóttir; Ann-Marie Svensson; Aldina Pivodic; Soffia Gudbjörnsdottir; Thomas Nyström; Hans Wedel; Annika Rosengren; Marcus Lind
Journal:  BMJ Open Diabetes Res Care       Date:  2019-04-14

7.  Analysis of the Peri-Operative Cost of Non-Traumatic Major Lower Extremity Amputation in Jordan.

Authors:  Qusai Aljarrah; Sohail Bakkar; Abdelwahab Aleshawi; Omar Al-Gharaibeh; Mooath Al-Jarrah; Radi Ebwayne; Mohammed Allouh; Ahmad K Abou-Foul
Journal:  Clinicoecon Outcomes Res       Date:  2020-01-09

8.  Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis.

Authors:  Ssu-Wei Cheng; Chin-Yuan Wang; Jin-Hua Chen; Yu Ko
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

9.  Costs and Length of Stay of Hospitalizations due to Diabetes-Related Complications.

Authors:  Ssu-Wei Cheng; Chih-Yuan Wang; Yu Ko
Journal:  J Diabetes Res       Date:  2019-09-08       Impact factor: 4.011

10.  Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden.

Authors:  Emelie Andersson; Sofie Persson; Nino Hallén; Åsa Ericsson; Desirée Thielke; Peter Lindgren; Katarina Steen Carlsson; Johan Jendle
Journal:  Diabetologia       Date:  2020-09-24       Impact factor: 10.122

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.